80 results
8-K
EX-99.1
RNLX
Renalytix Plc
28 May 24
Departure of Directors or Certain Officers
7:15am
assessment for rapid progressive decline in kidney function in adult patients with T2D and early CKD (stages 1-3). We believe that by understanding how
424B5
RNLX
Renalytix Plc
15 May 24
Prospectus supplement for primary offering
10:09am
Administration, or the FDA, authorized in vitro prognostic test that uses an artificial intelligence-enabled algorithm to aid in assessment of the risk … Administration-authorized in vitro prognostic test that uses an artificial intelligence-enabled algorithm to aid in assessment of the risk of progressive decline
8-K
EX-99.1
0t6vsx5 q42
15 May 24
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
7:00am
424B3
kl2p0uym1 yg3o09
7 May 24
Prospectus supplement
6:29pm
8-K
EX-99.1
75jb28k2na7j
26 Apr 24
Allotment and issue of the Second Tranche Placing Shares
7:43am
8-K
EX-99.1
83180z1pws0ogwxw
10 Apr 24
Unregistered Sales of Equity Securities
4:01pm
424B5
t29cpmtockc1lm50cqp1
9 Apr 24
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
famg8h w4am
8 Apr 24
Regulation FD Disclosure
7:44am
8-K
EX-10.1
jt7wkko07kylc4d dbpv
29 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-99.1
8yrkgwvzsi y22sfq
14 Mar 24
Guidelines highlight the importance of risk prediction and personalized treatment to reduce risk
7:15am
8-K
EX-10.1
r48o7fq6
13 Mar 24
Entry into a Material Definitive Agreement
7:00am
8-K
EX-99.1
u5mwusxb7pyjs6t6r ib
13 Mar 24
Entry into a Material Definitive Agreement
7:00am
8-K
EX-99.2
pidpep
13 Mar 24
Entry into a Material Definitive Agreement
7:00am
8-K
EX-99.1
1w7a1a
4 Mar 24
Regulation FD Disclosure
6:37am
8-K
m9utn1v8zthup1yt7vf
29 Feb 24
Regulation FD Disclosure
6:05am
8-K
EX-99.1
mrlala7534nkrr
15 Feb 24
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024
7:00am